Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02744352Terminated
Randomised, open-label trial of ropivacaine in postoperative pain, sponsored by University of Pennsylvania. Primary endpoint: Visual Analog Scale at 72 hours. Started Oct 2016; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02744352.